ATHE

Alterity Therapeutics Limited

Price

$3.68

return (12m)

-6.84%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

ATHE price

Alterity Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ATHE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-18.58%

3 months

-24.74%

1 year

-6.84%

2 years

177.74%

5 years

-70.79%

10 years

-91.86%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ATHE

Valuation

P/E

0.00

Sector -3.51

Industry -3.51

P/BV

0.00

Sector 1.99

Industry 1.99

P/Revenue (PSR)

Sector 2.05

Industry 2.05

EV/EBITDA

Sector -215.71

Industry -215.71

EV/EBIT

Sector -46.22

Industry -46.22

P/EBITDA

Sector -21.18

Industry -21.18

P/EBIT

Sector -28.19

Industry -28.19

P/Total Assets

Sector 1.18

Industry 1.18

P/Net Current Assets

Sector -10.00

Industry -10.00

P/Working Capital

Sector 1.60

Industry 1.60

EPS

Sector -1.80

Industry -1.80

BVPS

Sector 2.03

Industry 2.03

Efficiency

Gross Margin

0.00%

Sector 41.43%

Industry 41.43%

EBITDA Margin

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

Sector -4,221,130.86%

Industry -4,221,130.86%

Operating Margin

0.00%

Sector -35.37%

Industry -35.37%

Net Profit Margins

0.00%

Sector -36.08%

Industry -36.08%

Asset Turnover

Sector 0.03

Industry 0.03

Profitability

ROE

Sector -57.16%

Industry -57.16%

ROA

Sector -59.52%

Industry -59.52%

ROIC

0.00%

Sector -2,363.38%

Industry -2,363.38%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.91

Industry 2.91

Net Debt / EBITDA

Sector -14,058,646.59

Industry -14,058,646.59

Net Debt / EBIT

Sector -8.05

Industry -8.05

Net Debt / Equity

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

Sector 0.00

Industry 0.00

Equity/Assets

Sector 0.46

Industry 0.46

Liabilities/Assets

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals ATHE

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ATHE Alterity Therapeutics Limited	$3.68	-16.17%	0.00%	0.00	0.00	0.00%	0.00%
JNJ Johnson & Johnson	$269.99	56.27%	1.96%	30.90	7.65	24.76%	21.48%
PFE Pfizer Inc.	$28.31	25.77%	6.08%	37.23	1.89	5.07%	6.80%
ABBV AbbVie Inc.	$263.16	23.44%	2.60%	73.78	-78.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.62	-27.65%	4.80%	9.44	5.02	53.11%	35.32%
MRK Merck & Co. Inc.	$147.79	92.78%	2.29%	114.37	8.64	7.56%	4.77%
AZN AstraZeneca PLC	$166.12	14.91%	1.95%	19.85	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.01	48.57%	4.09%	13.50	5.62	41.59%	18.87%
ZTS Zoetis Inc.	$69.90	-49.71%	2.99%	11.07	9.27	83.77%	27.69%
AMGN Amgen Inc.	$409.53	50.71%	2.43%	25.29	18.92	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$789.37	42.66%	0.47%	18.75	2.56	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$114.87	51.86%	0.00%	32.57	93.84	288.13%	24.86%
MCK McKesson Corporation	$863.15	14.07%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$521.52	38.47%	0.00%	30.03	6.53	21.76%	35.00%
CAH Cardinal Health Inc.	$220.60	44.54%	0.93%	30.18	-18.99	-62.92%	0.67%
ARGX argenx SE	$957.38	31.19%	0.00%	1.85	2.21	119.72%	44.81%
HRMY Harmony Biosciences Holdings Inc.	$41.02	53.29%	0.00%	13.11	2.38	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ATHE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Alterity Therapeutics

Alterity Therapeutics Limited

Average Investor10 user rating

4.0 (1 people)

United States

29 years

Founded: 1997

2002

Time since IPO - 24 years

11

Employees

Alterity Therapeutics Limited (United States) is listed on the Nasdaq and has a market capitalization of $62.56 million, with shareholders equity totaling $-.

The company employs approximately 11 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Alterity Therapeutics Limited reported $- in revenue, generating net income of $-.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ATHE.

Market cap

$62.56 million

Net worth

Assets

Total Shares Outstanding

17.00 million

17,000,000

Average Daily Trading Volume

$14.41 Thousand

$14,406.00

Sector

Health Care

Industry

Biotechnology

ATHE

ATHE revenue and profits

Financial Results ATHE

DRAG THE FRAME TO SEE MORE DATA

ATHE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$863.15 14,07% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$220.60 45,03% (12M)

P/E

30.18

0.93%

ROE

-62.92%

P/BV

-18.99

JNJ - Johnson & Johnson

$269.99 53,64% (12M)

P/E

30.90

1.96%

ROE

24.76%

P/BV

7.65

ABBV - AbbVie

$263.16 23,09% (12M)

P/E

73.78

2.60%

ROE

-106.44%

P/BV

-78.53

MRK - Merck & Co.

$147.79 94,36% (12M)

P/E

114.37

2.29%

ROE

7.56%

P/BV

8.64

AZN - AstraZeneca

$166.12 13,98% (12M)

P/E

19.85

1.95%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$28.31 27,52% (12M)

P/E

37.23

6.08%

ROE

5.07%

P/BV

1.89

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$863.15 14,07% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$220.60 45,03% (12 M)

P/L

30.18

0.93%

ROE

-62.92%

P/VP

-18.99

JNJ - Johnson & Johnson

$269.99 53,64% (12 M)

P/L

30.90

1.96%

ROE

24.76%

P/VP

7.65

ABBV - AbbVie

$263.16 23,09% (12 M)

P/L

73.78

2.60%

ROE

-106.44%

P/VP

-78.53

MRK - Merck & Co.

$147.79 94,36% (12 M)

P/L

114.37

2.29%

ROE

7.56%

P/VP

8.64

AZN - AstraZeneca

$166.12 13,98% (12 M)

P/L

19.85

1.95%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$28.31 27,52% (12 M)

P/L

37.23

6.08%

ROE

5.07%

P/VP

1.89

Frequently Asked Questions

What is the price of Alterity Therapeutics (ATHE) today?

The current price of Alterity Therapeutics (ATHE) is $3.68. The stock began the year trading around $3.08 and is currently priced at $3.68. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Alterity Therapeutics (ATHE) pay dividends?

Alterity Therapeutics (ATHE) did not pay dividends over the past year.

Is Alterity Therapeutics (ATHE) a good investment?

Alterity Therapeutics (ATHE) is currently trading at $3.68 with a P/E ratio of 0.00. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -6.84%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Alterity Therapeutics (ATHE) stock?

You can buy Alterity Therapeutics (ATHE) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ATHE and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Alterity Therapeutics (ATHE) yield today?

Over the past month, Alterity Therapeutics (ATHE) has returned -18.58% — -6.84% over the past year, and -70.79% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Alterity Therapeutics (ATHE) today at the current price of $3.68 your total investment would be $368.00.

Based on historical performance, the investment would have grown to approximately:

$342.83 after 1 year
$107.49 after 5 years
$29.96 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ATHE

Alterity Therapeutics Limited

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ATHE

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ATHE WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Alterity Therapeutics

Alterity Therapeutics Limited

United States

29 years

2002

11

PROFIT X PRICE ATHE

Financial Results ATHE

ATHE cash flow

Asset, Revenue and Profit Growth - ATHE

ATHE balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions